Document is current
Any future updates will be listed below
-
Authors
Bywall, Karin Schölin http://orcid.org/0000-0002-5865-5590
Esbensen, Bente Appel
Heidenvall, Marie
Erlandsson, Inger
Lason, Marta
Hansson, Mats
Johansson, Jennifer Viberg
-
Funding
Funding for this research was provided by:
Vinnova, Innovationsfonden and The Research Council of Norway, under the frame of Nordforsk (Grant agreement no. 90825, Project NORA)
Mälardalen University
- License Information
-
More Information
Article History
Received: 12 September 2022
Accepted: 21 June 2023
First Online: 3 July 2023
Declarations
:
: The study was approved by the Ethics Review Authority in Sweden (Dnr 2020–00556). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual respondents included in the study. The authors confirm that all patient/personal identifiers have been removed or altered so the patient(s)/person(s) described cannot be identified through the details provided.
: Not Applicable.
: The authors KSB, MGH and JVJ declare no competing interests.BAE has received speaking fees from Pfizer and Lilly.MH and IE are supported by the Swedish Rheumatism Association as patient research partners. ML is employed at ELSA Science.
